Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment

a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adh...

Descripción completa

Detalles Bibliográficos
Autor principal: De Franceschi, Lucia
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033152/
https://www.ncbi.nlm.nih.gov/pubmed/21415994
http://dx.doi.org/10.4084/MJHID.2009.024
_version_ 1782197549359169536
author De Franceschi, Lucia
author_facet De Franceschi, Lucia
author_sort De Franceschi, Lucia
collection PubMed
description a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adhesive events, might constitute new pharmacological targets for treating sickle cell disease.
format Text
id pubmed-3033152
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-30331522011-03-17 Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment De Franceschi, Lucia Mediterr J Hematol Infect Dis Review Article a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adhesive events, might constitute new pharmacological targets for treating sickle cell disease. Università Cattolica del Sacro Cuore 2009-12-20 /pmc/articles/PMC3033152/ /pubmed/21415994 http://dx.doi.org/10.4084/MJHID.2009.024 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
De Franceschi, Lucia
Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title_full Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title_fullStr Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title_full_unstemmed Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title_short Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
title_sort pathophisiology of sickle cell disease and new drugs for the treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033152/
https://www.ncbi.nlm.nih.gov/pubmed/21415994
http://dx.doi.org/10.4084/MJHID.2009.024
work_keys_str_mv AT defranceschilucia pathophisiologyofsicklecelldiseaseandnewdrugsforthetreatment

Ejemplares similares